The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

But in a twist this August, a separate part of North Carolina’s government allowed the Medicaid program to start covering the ...

Ozempic (semaglutide) is an injectable, prescription-only medication that suppresses appetite and slows down digestion. Here, ...

Health experts have issued an urgent warning about counterfeit weight loss medications being sold through fake online ...

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...

A NEW weight loss jabs dubbed the “King Kong” is set to hit the Irish market as soon as next year. Mounjaro can be used to ...

“We know in smaller studies that when women with PCOS take semaglutide, it increases the regularity of the menstrual cycle, ...

Officials said they were aware of reports of fake medicines including Ozempic being sold on scam websites and there was 'no way of knowing what is really in them'.

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.